Rupa Wong, MD
Ophthalmology · Honolulu, HINPI 1144288184
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $55,002 of the $71,585 with a category attached, or 76.8%. Coopervision Inc. accounts for 62.5% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2020 at $31,383 and has fallen 51.6% since, to $15,181 in 2025. Among ophthalmology clinicians in HI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 64 payments — averaging $1118.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopervision Inc.$45K
- Alcon$15K
- Haag-streit USA, Inc.$8K
- Tarsus Pharmaceuticals, Inc.$2K
- Amgen$578
- Sun Pharmaceutical Industries Inc.$227
- plus $1K from 10 others
What the payments were for
- Consulting fees$10,13814%
- Speaking & faculty fees$55,00277%
- Food & beverage$3,9446%
- Education$2,5013%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coopervision Inc. | 17 | $44,759 |
| Alcon | 10 | $15,298 |
| Haag-streit USA, Inc. | 9 | $7,724 |
| Tarsus Pharmaceuticals, Inc. | 4 | $1,856 |
| Amgen(2 entities) | 5 | $578 |
| Sun Pharmaceutical Industries Inc. | 2 | $227 |
| Aerie Pharmaceuticals, Inc. | 2 | $202 |
| Sight Sciences, Inc. | 3 | $180 |
| Oyster Point Pharma, Inc. | 2 | $168 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $135 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $125 |
| Dompe US, Inc. | 1 | $118 |
| Apellis Pharmaceuticals, Inc. | 1 | $112 |
| AbbVie(2 entities) | 3 | $81 |
| Kala Pharmaceuticals, Inc. | 1 | $21 |
| Travere Therapeutics, Inc. | 1 | $1 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MiSight Contact Lens$44,672
- Pataday$14,500
- XDEMVY$268
- Clareon$256
- Rhopressa$234
- Rocklatan$234
- BROMSITE$227
- OMNI(R) SURGICAL SYSTEM (US)$149
- ReSTOR$141
- TEPEZZA$136
- Tecnis Multifocal Family of 1-piece IOLS$125
- CEQUA$123
- XELPROS$123
- TYRVAYA$120
- Ryzumvi$120
- Oxervate$118
- Syfovre$112
- LOTEMAX$112
- Hydrus Microstent$111
- AcrySof IQ PanOptix$104
How this compares
$71,585 in reported general payments places this provider in the 90th percentile of 120 ophthalmology providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Honolulu
- Neda NikpoorHonolulu$293K
- Carlton YuenHonolulu$175K
- Alan FaulknerHonolulu$135K
- Michael BennettHonolulu$108K
- Jeffrey PetersonHonolulu$77K
- Jon PortisHonolulu$20K
- Tyrie JenkinsHonolulu$19K
- John OlkowskiHonolulu$15K
- Claudia HootenHonolulu$14K
- Kenneth ChangHonolulu$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.